ImmunoCellular Therapeutics Ltd. (IMUC) gained 5.48% or 0.01 to $0.26. It is approximately 721292 shares traded, which is 50.97% compare to the average total volume 1.42 million. The market cap of IMUC is $9.15 million. The year to date change is -28.18%. The 52 week price range is from $0.17 to $3.6. Price of IMUC have changed -6.98% during last week. It have changed -3.33% over last month, -22.73% over last 3 months, -11.96% over last 6 months and -90.63% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for IMUC is 0.28. It is 7.69% above current price. The 200-day Moving Averages for IMUC is 0.50. It is 92.31% above current price. The 52-week High is 3.6. It is 1284.62% from the current price. The 52-week Low is 0.17. It is -34.62% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of IMUC is 1.89 on 2018-02-15. Short % to float is 8.92%. There are some statistics of IMUC. It is has market cap $9.15 million. The share outstanding is 35.20 million. The average volume is 1.42 million. The percent of top 15 Institution holding is 6.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of IMUC is -385.10%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of IMUC is -149.26%.